niclosamide has been researched along with Granulocytic Leukemia, Chronic in 3 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, B | 2 |
| Wang, C | 2 |
| Shen, Y | 1 |
| Pan, J | 2 |
| Li, J | 1 |
| Du, X | 1 |
| Ding, K | 1 |
| Liu, Z | 1 |
| Li, Y | 1 |
| Lv, C | 1 |
| Wang, L | 1 |
| Song, H | 1 |
3 other studies available for niclosamide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.
Topics: Animals; Anthelmintics; Apoptosis; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; F | 2018 |
Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
Topics: Animals; Anthelmintics; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Self Renewal; Chromatin | 2017 |
Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.
Topics: Anthelmintics; Antigens, CD34; Apoptosis; Cell Line, Tumor; Cell Self Renewal; Dasatinib; Drug Syner | 2016 |